Hollow celebration of 50 years of human-rights campaigning

Dark Matter Search Results from 4.2 Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2025

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Physical review letters·2025

Constraints on Covariant Dark-Matter-Nucleon Effective Field Theory Interactions from the First Science Run of the LUX-ZEPLIN Experiment.

Physical review letters·2024

Involving citizen scientists in monitoring arthropod vectors of human and zoonotic diseases: The case of Mosquito Alert in Italy.

The Science of the total environment·2024

Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer.

Practical radiation oncology·2024

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Those left behind: the impact of resident suicide on trainees, faculty, departments, and institutions.

Academic medicine : journal of the Association of American Medical Colleges·2026

Historical Thinking in the Clinic.

Journal of general internal medicine·2026

Yan Festschrift editorial.

The Journal of chemical physics·2026

Academic pharmacy must do better to accommodate its faculty workforce.

Research in social & administrative pharmacy : RSAP·2026

Psychometric Properties of an Arabic Translation of the Dysfunctional Beliefs and Attitudes About Sleep Scale (DBAS-16) in a Sample of University Students.

International journal of methods in psychiatric research·2026

Conceptualizing spiritual care in the U.S. through chaplain activities in research: a scoping review sub-analysis.

Journal of health care chaplaincy·2026

Related Experiment Videos

Hollow celebration of 50 years of human-rights campaigning

Related Concept Videos

Dark Matter Search Results from 4.2 Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Constraints on Covariant Dark-Matter-Nucleon Effective Field Theory Interactions from the First Science Run of the LUX-ZEPLIN Experiment.

Involving citizen scientists in monitoring arthropod vectors of human and zoonotic diseases: The case of Mosquito Alert in Italy.

Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Those left behind: the impact of resident suicide on trainees, faculty, departments, and institutions.

Historical Thinking in the Clinic.

Yan Festschrift editorial.

Academic pharmacy must do better to accommodate its faculty workforce.

Psychometric Properties of an Arabic Translation of the Dysfunctional Beliefs and Attitudes About Sleep Scale (DBAS-16) in a Sample of University Students.

Conceptualizing spiritual care in the U.S. through chaplain activities in research: a scoping review sub-analysis.

Related Experiment Videos

Hollow celebration of 50 years of human-rights campaigning

Related Concept Videos

Related Articles